Cargando…
Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis
Serum miRNAs have gained great popularity to act as circulating biomarkers of several cancers. In this study, we aimed to evaluate the diagnostic efficiency of serum miR-21 as novel biomarkers for patients with hepatocellular carcinoma (HCC) and other controls. A total of 533 individuals were recrui...
Autores principales: | Guo, Xin, Lv, Xiaohui, Lv, Xing, Ma, Yueyun, Chen, Lin, Chen, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546461/ https://www.ncbi.nlm.nih.gov/pubmed/28477010 http://dx.doi.org/10.18632/oncotarget.17211 |
Ejemplares similares
-
Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma
por: Huang, Chunyu, et al.
Publicado: (2021) -
Serum miR-214 Serves as a Biomarker for Prodromal Parkinson’s Disease
por: Li, Lanting, et al.
Publicado: (2021) -
miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
por: Ivo D’Urso, Pietro, et al.
Publicado: (2015) -
Circulating exosomal miR‐363‐5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer
por: Wang, Xin, et al.
Publicado: (2021) -
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
por: Zhang, Ming, et al.
Publicado: (2021)